This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Release Of Accelrys Electronic Lab Notebook Transforms Laboratory Operations

SAN DIEGO, May 20, 2013 /PRNewswire/ --  Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the latest release of the Accelrys Electronic Lab Notebook (AELN), which now offers extensive integration with the unifying, scientifically aware Accelrys Enterprise Platform (AEP). Expanded integration with AEP supports the management and orchestration of information, data, people, tasks and processes within and across labs, enhancing collaboration, externalization, chemistry harmonization, instrument integration, experiment design and reporting.


"LEO Pharma is using the Accelrys Lab Notebook to support execution and documentation of medicinal chemistry experiments, both single-compound and parallel synthesis," said Dr. Ulrik de Lichtenberg, head of research informatics and data management at LEO Pharma. "We have extended the functionality of the core ELN product by leveraging the Accelrys Enterprise Platform to create an electronic process exactly matched to our scientific workflows. The ELN platform has strengthened our internal knowledge sharing, and at the same time provided us with a seamless process for capturing documentation needed to obtain and defend patents."  

As a key application within the Accelrys Process Management and Compliance Suite of software products, the latest release of the Accelrys Electronic Lab Notebook also offers significant synthetic chemistry enhancements and full integration of interactive Pipeline Pilot scientific authoring protocols that speed data access, review and analysis for medicinal, analytical, formulations and process scientists using the notebook.

The AEP provides a broad, secure foundation supporting tighter integration of the latest notebook release with other applications within the Accelrys Process Management and Compliance Suite and with the platform's extensive scientific Component Collections. The integration with the Accelrys Enterprise Platform has been greatly expanded in this latest notebook release, providing industry-leading data analysis and reporting capabilities that deliver improved experiment insight and productivity for virtually any scientific discipline with lower cost of ownership. For example, the platform speeds experiment design and analysis by enabling scientists to register chemical and biological entities directly within the AELN using the Accelrys Chemical Registration or Accelrys Biological Registration applications.

"The latest release of the Accelrys Electronic Lab Notebook moves beyond the paperless lab to a better connected, more harmonized and compliant lab ecosystem extending from research to manufacturing," said Ken Rapp, managing director of Accelrys' analytical, development, quality and manufacturing solutions. "Improved handling of chemistry workflows in accordance with the way bench chemists actually perform their research speeds lab productivity, while automated Pipeline Pilot workflows within the Notebook accelerate product development in Chemistry, Manufacturing and Control."

The latest release of the Accelrys Electronic Lab Notebook also offers significant enhancements to overall usability and synthetic chemistry for medicinal, analytical, formulations and process scientists including:
  • Improved parallel chemistry supporting medicinal chemists' workflows with step-by-step enumeration on multi-step reaction schemes and salt stripping from enumerated products
  • Flexible, intuitive reaction scaling for both single-step and multiple-step reactions, requiring just two mouse clicks to visualize scaling impact
  • Enhanced experiment cloning keeps experiments compliant with latest SOPs and templates, improving experiment management and administration
  • Better management of favorite materials and faster experiment design through easier access to commonly used reagents and solvents

Join us in Princeton, NJ on June 4-5 at the 2013 Accelrys Process Management & Compliance Suite User Conference and hear Accelrys Electronic Lab Notebook use cases from Pfizer, Colgate Palmolive, Johnson & Johnson, BMS and more.

Gartner rates Accelrys Electronic Lab Notebook "Very High" or "High" in domain expertise across six major scientific disciplines. Download the Gartner Report "Manufacturers Must Consider Scientific Domain Expertise During ELN Selection."

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs